. . . . "RIV/68081715:_____/05:00020840!RIV06-AV0-68081715" . . . . "Pokroky v enantioselektivn\u00ED TLC l\u00E9\u010Div" . "159;162" . . "2"^^ . "1"^^ . . "Enantioselective TLC represents a still developing field of analysis of therapeutic agents. In recent years, similarly as in HPLC, mainly direct separations of enantiomers without their preceding derivatization have been published, preferentially using chiral stationary phases, separations with a chiral selector in the mobile phase being less frequent. I the future, a larger choice of commercially available chiral stationary phases could contribute to a more widespread use of enantioselective TLC."@en . "54" . "Pokroky v enantioselektivn\u00ED TLC l\u00E9\u010Div" . . "\u010Cesk\u00E1 a Slovensk\u00E1 farmacie" . "[94B29675558B]" . "eantiomers; TLC; therapeutic agents"@en . "Advances in enantioselective TLC of therapeutic agents"@en . . "Pokroky v enantioselektivn\u00ED TLC l\u00E9\u010Div"@cs . "4"^^ . "1210-7816" . . "536530" . "RIV/68081715:_____/05:00020840" . "4" . "Pokroky v enantioselektivn\u00ED TLC l\u00E9\u010Div"@cs . . "Enantioselektivn\u00ED TLC je dosud se vyv\u00EDjej\u00EDc\u00ED oblast\u00ED anal\u00FDzy l\u00E9\u010Div. V posledn\u00EDch letech byla podobn\u011B, jako je tomu v HPLC, publikov\u00E1na p\u0159edev\u0161\u00EDm p\u0159\u00EDm\u00E1 d\u011Blen\u00ED enantiomer\u016F bez jejich p\u0159edchoz\u00ED derivatizace. P\u0159ednostn\u011B k nim byly pou\u017Eity chir\u00E1ln\u00ED stacion\u00E1rn\u00ED f\u00E1ze, d\u011Blen\u00ED s chir\u00E1ln\u00EDm selektorem v mobiln\u00ED f\u00E1z\u00ED byla m\u00E9n\u011B \u010Dast\u00E1. K \u0161ir\u0161\u00EDmu vyu\u017Eit\u00ED enantioselektivn\u00ED TLC v budoucnosti by mohl p\u0159isp\u011Bt v\u011Bt\u0161\u00ED v\u00FDb\u011Br chir\u00E1ln\u00EDch stacion\u00E1rn\u00EDch f\u00E1z\u00ED komer\u010Dn\u011B dostupn\u00FDch." . "\u0160lais, Karel" . "Z(AV0Z40310501)" . "CZ - \u010Cesk\u00E1 republika" . . . "Enantioselektivn\u00ED TLC je dosud se vyv\u00EDjej\u00EDc\u00ED oblast\u00ED anal\u00FDzy l\u00E9\u010Div. V posledn\u00EDch letech byla podobn\u011B, jako je tomu v HPLC, publikov\u00E1na p\u0159edev\u0161\u00EDm p\u0159\u00EDm\u00E1 d\u011Blen\u00ED enantiomer\u016F bez jejich p\u0159edchoz\u00ED derivatizace. P\u0159ednostn\u011B k nim byly pou\u017Eity chir\u00E1ln\u00ED stacion\u00E1rn\u00ED f\u00E1ze, d\u011Blen\u00ED s chir\u00E1ln\u00EDm selektorem v mobiln\u00ED f\u00E1z\u00ED byla m\u00E9n\u011B \u010Dast\u00E1. K \u0161ir\u0161\u00EDmu vyu\u017Eit\u00ED enantioselektivn\u00ED TLC v budoucnosti by mohl p\u0159isp\u011Bt v\u011Bt\u0161\u00ED v\u00FDb\u011Br chir\u00E1ln\u00EDch stacion\u00E1rn\u00EDch f\u00E1z\u00ED komer\u010Dn\u011B dostupn\u00FDch."@cs . "Advances in enantioselective TLC of therapeutic agents"@en . "\u0160ubert, J." .